The company maintains a debt-to-equity ratio of 0.74 as of 2026Q1, with a significant $110.5 billion goodwill concentration that warrants close monitoring for potential impairment risks.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Assets | 312.64B | 309.58B | 298.28B | 273.72B | 245.71B | 212.21B | 197.29B | 173.89B | 152.22B | 139.06B | 122.68B | 111.38B | 86.38B | 81.88B | 80.89B | 67.89B | 63.06B | 59.05B | 55.81B | 50.9B | 48.32B | 41.37B | 27.88B | 17.63B | 14.16B | 12.49B | 11.05B | 10.27B | 9.7B | 7.62B | 7B |
| Asset Growth % | 17.91% | 3.79% | 8.97% | 11.4% | 15.79% | 7.56% | 13.46% | 14.23% | 9.47% | 13.35% | 10.14% | 28.94% | 5.5% | 1.23% | 19.14% | 7.65% | 6.8% | 5.79% | 9.66% | 5.34% | 16.79% | 48.41% | 58.1% | 24.5% | 13.44% | 12.96% | 7.59% | 5.9% | 27.26% | 8.95% | 13.56% |
| Total Investment Assets | 4M | 58.01B | 56.16B | 4.2B | 48.27B | 45.65B | 44.1B | 40.47B | 35.97B | 31.85B | 26.71B | 20.78B | 20.57B | 21.54B | 20.74B | 18.74B | 16.78B | 14.55B | 14.15B | 13.42B | 10.26B | 9.56B | 8.26B | 7.21B | 5.2B | 4.16B | 3.63B | 3.11B | 2.78B | 3.29B | 2.42B |
| Long-Term Investments | 216.5B | 54.25B | 52.35B | 0 | 43.73B | 43.11B | 41.24B | 37.21B | 32.51B | 28.34B | 23.87B | 18.79B | 18.83B | 19.61B | 17.71B | 16.17B | 14.71B | 13.31B | 13.37B | 12.67B | 9.64B | 8.97B | 7.75B | 6.73B | 4.5B | 3.89B | 3.43B | 2.57B | 2.61B | 2.79B | 1.8B |
| Short-Term Investments | 3.23B | 3.76B | 3.8B | 4.2B | 4.55B | 2.53B | 2.86B | 3.26B | 3.46B | 3.51B | 2.85B | 1.99B | 1.74B | 1.94B | 3.03B | 2.58B | 2.07B | 1.24B | 783M | 754M | 620M | 590M | 514M | 486M | 701M | 270M | 200M | 546M | 170M | 506M | 610.57M |
| Total Current Assets | 91.13B | 90.58B | 85.78B | 78.44B | 69.07B | 61.76B | 53.72B | 42.63B | 38.69B | 37.08B | 33.75B | 31.64B | 23.56B | 20.38B | 21.05B | 20.35B | 18.39B | 18.2B | 14.99B | 15.54B | 16.04B | 10.64B | 8.24B | 6.12B | 5.17B | 4.95B | 4.41B | 4.57B | 4.28B | 2.19B | 2.74B |
| Cash & Equivalents | 28B | 24.36B | 25.31B | 25.43B | 23.36B | 21.38B | 16.92B | 10.98B | 10.87B | 11.98B | 10.43B | 10.92B | 7.5B | 7.28B | 8.41B | 9.43B | 9.12B | 9.8B | 7.43B | 8.87B | 10.32B | 5.42B | 3.99B | 2.26B | 1.13B | 1.54B | 1.42B | 1.6B | 1.64B | 750M | 1.04B |
| Receivables | 187.46B | 52.72B | 48.45B | 38.97B | 17.68B | 14.22B | 12.87B | 11.82B | 11.39B | 9.57B | 8.15B | 6.52B | 4.25B | 3.05B | 5.6B | 4.55B | 3.7B | 3.79B | 3.64B | 2.9B | 1.32B | 1.21B | 906M | 745M | 664M | 856M | 867M | 912M | 965M | 768M | 605.8M |
| Other Current Assets | 33.31B | 0 | 8.21B | 9.84B | 23.48B | 23.64B | 21.07B | 16.57B | 12.98B | 12.03B | 12.32B | 12.21B | 10.07B | 8.12B | 3.24B | 2.09B | 2.01B | 1.84B | 1.69B | 2.6B | 3.78B | 3.42B | 2.83B | 2.36B | 2.29B | 1.96B | 1.92B | 1.5B | 1.5B | 169M | 486.57M |
| Goodwill & Intangibles | 394.29B | 130.97B | 130B | 118.93B | 107.75B | 85.84B | 82.19B | 76.01B | 68.23B | 63.05B | 56.13B | 52.84B | 36.61B | 35.45B | 35.97B | 26.77B | 25.66B | 24.3B | 22.42B | 18.59B | 18.73B | 18.23B | 10.68B | 3.69B | 3.48B | 2.81B | 2.91B | 2.86B | 2.52B | 2.28B | 2.14B |
| Goodwill | 0 | 110.5B | 106.73B | 103.73B | 93.35B | 75.8B | 71.34B | 65.66B | 58.91B | 54.56B | 47.58B | 44.45B | 32.94B | 31.6B | 31.29B | 23.98B | 22.75B | 20.73B | 20.09B | 16.85B | 16.82B | 16.21B | 9.47B | 3.51B | 3.36B | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 20.47B | 23.27B | 15.19B | 14.4B | 10.04B | 10.86B | 10.35B | 9.32B | 8.49B | 8.54B | 8.39B | 3.67B | 3.84B | 4.68B | 2.79B | 2.91B | 3.58B | 2.33B | 1.74B | 1.9B | 2.02B | 1.21B | 180M | 122M | 2.81B | 2.91B | 2.86B | 2.52B | 2.28B | 2.14B |
| PP&E (Net) | 0 | 10.76B | 10.55B | 11.45B | 10.13B | 8.97B | 8.63B | 8.7B | 8.46B | 7.01B | 5.9B | 4.86B | 4.42B | 4.01B | 3.94B | 2.52B | 2.2B | 946M | 2.18B | 2.12B | 1.89B | 1.65B | 1.14B | 1.03B | 955M | 847M | 303M | 278M | 294M | 364M | 312.98M |
| Other Assets | 164.73B | 23.01B | 19.59B | 64.91B | 12.26B | 107.33B | 102.33B | 94.05B | 81.02B | 1.39B | 276M | 2.39B | 2.42B | 2.01B | 1.75B | 1.62B | 1.71B | 2.29B | 2.44B | 1.59B | 1.45B | 1.25B | -277M | 64M | 52M | 3.89B | 3.43B | 2.57B | 2.61B | 2.79B | 1.8B |
| Total Liabilities | 207.32B | 207.88B | 195.69B | 174.8B | 159.36B | 135.73B | 126.75B | 111.73B | 95.99B | 87.03B | 82.27B | 75.92B | 52.54B | 48.56B | 47.59B | 39.6B | 37.24B | 35.44B | 35.03B | 30.84B | 27.51B | 23.64B | 17.16B | 12.51B | 9.74B | 8.6B | 7.37B | 6.41B | 5.66B | 3.09B | 3.17B |
| Total Debt | 77.92B | 78.39B | 76.9B | 67.44B | 57.62B | 46B | 43.47B | 40.68B | 36.55B | 31.69B | 32.97B | 32.09B | 17.41B | 16.86B | 16.75B | 11.64B | 11.14B | 11.17B | 12.79B | 11.01B | 7.46B | 7.11B | 4.02B | 1.98B | 1.76B | 1.58B | 1.21B | 991M | 708M | 19M | 30.76M |
| Net Debt | 49.92B | 54.02B | 51.59B | 42.01B | 34.26B | 24.63B | 26.55B | 29.69B | 25.69B | 19.71B | 22.54B | 21.17B | 9.91B | 9.58B | 8.35B | 2.21B | 2.02B | 1.37B | 5.37B | 2.14B | -2.86B | 1.69B | 32M | -283M | 631M | 44M | -210M | -614M | -936M | -731M | -1.01B |
| Long-Term Debt | 71.44B | 72.32B | 72.36B | 58.26B | 54.51B | 42.38B | 38.65B | 36.81B | 34.58B | 28.84B | 25.78B | 25.33B | 16.01B | 14.89B | 14.04B | 10.66B | 8.66B | 9.01B | 11.34B | 9.06B | 5.97B | 3.83B | 3.35B | 1.75B | 950M | 900M | 650M | 400M | 249M | 19M | 30.76M |
| Short-Term Debt | 6.48B | 6.07B | 4.54B | 5.31B | 3.11B | 3.62B | 4.82B | 3.87B | 1.97B | 2.86B | 7.19B | 6.63B | 1.4B | 1.97B | 2.71B | 982M | 2.48B | 2.16B | 1.46B | 1.95B | 1.48B | 3.26B | 673M | 229M | 811M | 684M | 559M | 591M | 459M | 0 | 0 |
| Total Current Liabilities | 114.12B | 114.9B | 103.77B | 99.05B | 89.24B | 78.29B | 72.42B | 61.78B | 53.21B | 50.46B | 49.22B | 42.9B | 30.62B | 27.88B | 27.12B | 23.92B | 23.7B | 22.16B | 20.19B | 18.49B | 18.5B | 16.64B | 11.33B | 8.77B | 8.38B | 7.49B | 6.57B | 5.89B | 5.34B | 2.57B | 2.64B |
| Accounts Payable | 39.66B | 38.03B | 68.56B | 31.96B | 56.77B | 49.13B | 44.37B | 40.7B | 36.6B | 33.05B | 29.75B | 26.32B | 21.29B | 19.03B | 17.99B | 16.65B | 9.22B | 9.36B | 8.66B | 8.33B | 8.08B | 7.26B | 5.54B | 5.73B | 5.2B | 0 | 0 | 0 | 0 | 0 | 73.08M |
| Deferred Revenue | 0 | 3.41B | 3.32B | 3.35B | 3.08B | 2.57B | 2.84B | 2.62B | 2.4B | 2.27B | 1.97B | 2.14B | 1.97B | 1.6B | 1.5B | 1.23B | 1.53B | 1.22B | 0 | 0 | 3.71B | 3.3B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 67.99B | 28.05B | 27.35B | 58.43B | 26.28B | 22.98B | 20.39B | 14.6B | 12.24B | 12.29B | 10.3B | 7.8B | 5.96B | 5.28B | 4.91B | 5.06B | 3.98B | 3.14B | 4.38B | 4.56B | 1.51B | -465M | 3.01B | 2.81B | 2.37B | 2.14B | 1.7B | 1.38B | 1.15B | 510M | 562.3M |
| Deferred Taxes | 6.97B | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 |
| Other Liabilities | 21.76B | 18.25B | 15.94B | 11.94B | 12.84B | 15.05B | 15.68B | 13.14B | 8.2B | 7.74B | 7.28B | 4.11B | 3.85B | 3.99B | 3.98B | 2.44B | 0 | 0 | 2.29B | 1.85B | 1.85B | 1.76B | 1.67B | 1.52B | 0 | 0 | 0 | 0 | 0 | 500M | 500M |
| Total Equity | 105.32B | 101.7B | 102.59B | 98.92B | 86.35B | 76.48B | 70.54B | 62.16B | 56.23B | 52.02B | 40.41B | 35.46B | 33.84B | 33.32B | 33.3B | 28.29B | 25.82B | 23.61B | 20.78B | 20.06B | 20.81B | 17.73B | 10.72B | 5.13B | 4.43B | 3.89B | 3.69B | 3.86B | 4.04B | 4.53B | 3.82B |
| Equity Growth % | 6.17% | -0.87% | 3.71% | 14.56% | 12.9% | 8.42% | 13.48% | 10.56% | 8.08% | 28.74% | 13.95% | 4.78% | 1.55% | 0.08% | 17.7% | 9.55% | 9.4% | 13.6% | 3.57% | -3.59% | 17.35% | 65.47% | 108.99% | 15.81% | 13.8% | 5.5% | -4.53% | -4.33% | -10.94% | 18.6% | 19.92% |
| Shareholders Equity | 103.89B | 94.11B | 92.66B | 88.76B | 77.77B | 71.76B | 65.49B | 57.62B | 51.7B | 49.83B | 38.4B | 33.73B | 32.45B | 32.15B | 31.18B | 28.29B | 25.82B | 23.61B | 20.78B | 20.06B | 20.81B | 17.73B | 10.72B | 5.13B | 4.43B | 3.89B | 3.69B | 3.86B | 4.04B | 4.53B | 3.82B |
| Minority Interest | 1.42B | 7.59B | 9.93B | 10.16B | 8.57B | 4.72B | 5.05B | 4.55B | 4.53B | 2.19B | 2.01B | 1.74B | 1.39B | 1.18B | 2.12B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 0 | 95.6B | 96.04B | 95.77B | 86.16B | 77.13B | 69.3B | 61.18B | 55.85B | 48.73B | 40.95B | 37.13B | 33.84B | 33.05B | 30.66B | 27.82B | 25.56B | 23.34B | 20.78B | 18.93B | 14.38B | 10.26B | 7.48B | 4.92B | 4.1B | 3.81B | 3.6B | 3.44B | 2.88B | 3.1B | 2.68B |
| Common Stock | 0 | 9M | 9M | 9M | 9M | 10M | 10M | 9M | 10M | 10M | 10M | 10M | 10M | 10M | 10M | 10M | 11M | 11M | 12M | 13M | 13M | 14M | 6M | 6M | 6M | 3M | 3M | 3M | 2M | 2M | 1.85M |
| Accumulated OCI | 0 | -2.06B | -3.39B | -7.03B | -8.39B | -5.38B | -3.81B | -3.58B | -4.16B | -2.67B | -2.68B | -3.33B | -1.39B | -908M | 438M | 461M | 252M | 253M | -52M | 98M | 15M | 33M | 132M | 149M | 148M | 44M | 90M | 165M | 44M | 29M | -6.99M |
| Return on Equity (ROE) | 11.54% | 11.8% | 14.3% | 24.16% | 24.71% | 23.51% | 23.21% | 23.38% | 22.15% | 22.85% | 18.5% | 16.78% | 16.73% | 16.89% | 17.94% | 19% | 18.75% | 17.22% | 14.58% | 22.77% | 21.58% | 21.67% | 32.65% | 34.64% | 32.5% | 24.09% | 19.49% | 14.38% | -3.87% | 11.01% | 10.14% |
| Return on Assets (ROA) | 3.87% | 3.97% | 5.04% | 8.62% | 8.79% | 8.44% | 8.3% | 8.49% | 8.23% | 8.07% | 6% | 5.88% | 6.68% | 6.91% | 7.43% | 7.85% | 7.59% | 6.66% | 5.58% | 9.38% | 9.27% | 8.9% | 11.37% | 10.41% | 10.15% | 7.76% | 6.9% | 5.69% | -1.92% | 6.29% | 5.41% |
| Equity / Assets | 33.69% | 32.85% | 34.39% | 36.14% | 35.14% | 36.04% | 35.75% | 35.75% | 36.94% | 37.41% | 32.94% | 31.84% | 39.18% | 40.7% | 41.17% | 41.67% | 40.95% | 39.98% | 37.23% | 39.42% | 43.07% | 42.86% | 38.44% | 29.08% | 31.26% | 31.16% | 33.37% | 37.6% | 41.62% | 59.48% | 54.64% |
| Debt / Equity | 0.74x | 0.77x | 0.75x | 0.68x | 0.67x | 0.60x | 0.62x | 0.65x | 0.65x | 0.61x | 0.82x | 0.91x | 0.51x | 0.51x | 0.50x | 0.41x | 0.43x | 0.47x | 0.62x | 0.55x | 0.36x | 0.40x | 0.38x | 0.39x | 0.40x | 0.41x | 0.33x | 0.26x | 0.18x | 0.00x | 0.01x |
| Book Value per Share | 115.74 | 111.76 | 110.43 | 105.46 | 90.89 | 80.00 | 73.40 | 64.35 | 57.20 | 52.81 | 41.74 | 36.67 | 34.32 | 32.57 | 31.83 | 26.03 | 22.83 | 20.02 | 16.74 | 14.74 | 14.84 | 13.30 | 8.14 | 4.15 | 3.49 | 2.98 | 2.74 | 2.72 | 2.65 | 2.97 | 2.57 |
| Tangible BV per Share | 115.74 | -32.17 | -29.51 | -21.33 | -22.53 | -9.79 | -12.13 | -14.33 | -12.22 | -11.19 | -16.24 | -17.98 | -2.81 | -2.08 | -2.55 | 1.40 | 0.15 | -0.59 | -1.32 | 1.08 | 1.49 | -0.37 | 0.03 | 1.17 | 0.74 | 0.83 | 0.58 | 0.71 | 1.00 | 1.47 | 1.13 |
Medical utilization cost inflation
As reported in recent financial statements, UnitedHealth Group's total assets grew to $312.6 billion by 2026Q1, yet the equity base has remained relatively stagnant, suggesting that the company is increasingly relying on debt-funded expansion to maintain its competitive position in a tightening regulatory environment.
The divergence between asset growth and equity accumulation indicates that the company's capital structure is becoming more leveraged over time. Investors should monitor whether this asset-heavy strategy continues to yield sufficient returns on invested capital, or if it merely reflects the rising cost of maintaining market share.
Based on the provided quarterly data, the company's debt-to-equity ratio has remained relatively stable near 0.74 as of 2026Q1, suggesting that management is utilizing debt strategically to fund its ongoing integration of healthcare services rather than as a necessity for basic operational survival.
While the debt load appears manageable, the consistency of the D/E ratio implies a disciplined approach to capital structure that prioritizes growth through acquisition. However, the reliance on debt to fuel this expansion warrants further investigation into the company's ability to service these obligations if medical utilization trends continue to pressure margins.
According to the latest balance sheet filings, goodwill accounts for a substantial portion of total assets at $110.5 billion as of 2025Q4, which suggests that the company's valuation is heavily dependent on the successful integration and performance of its past acquisitions.
The high concentration of intangible assets relative to total assets indicates that the company's book value is sensitive to potential impairment charges. If the expected synergies from the Optum ecosystem fail to materialize, the company may face significant write-downs that could impair its overall financial health.
As evidenced by the current ratio of 0.80 in 2026Q1, UnitedHealth Group maintains a relatively lean liquidity position, which may indicate that the company relies heavily on consistent operating cash flow to meet its short-term obligations rather than holding excess cash reserves.
This liquidity profile appears typical for a large-scale managed care organization, yet it leaves little room for error during periods of operational disruption. Investors should monitor whether this tight buffer is sufficient to navigate potential volatility in claims processing or unexpected spikes in medical utilization.
Quick answers to the most common questions about buying UNH stock.
As of 2025, UnitedHealth Group Incorporated (UNH) had total assets of $309.58B including $90.58B in current assets.
UnitedHealth Group Incorporated (UNH) carries total debt of $78.39B, offset by $28.12B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
UnitedHealth Group Incorporated (UNH) has total shareholders' equity (book value) of $94.11B ($111.76 book value per share). Book value represents the net worth of the company belonging to common stock holders.
UnitedHealth Group Incorporated (UNH) reported a current ratio of 0.79x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.